Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank78
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-17.63M
↑ 28% vs avg
Percentile
P78
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-24.50M
Historical baseline
PeriodValueYoY Change
TTM$-17.63M+71.1%
2024$-60.93M-57.9%
2023$-38.58M-106.8%
2022$-18.65M+32.4%
2021$-27.58M+8.7%
2020$-30.21M-10.2%
2019$-27.41M-53.3%
2018$-17.87M-290.0%
2017$-4.58M-184.5%
2016$-1.61M-